کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6152 466 2013 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells
موضوعات مرتبط
مهندسی و علوم پایه مهندسی شیمی بیو مهندسی (مهندسی زیستی)
پیش نمایش صفحه اول مقاله
Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells
چکیده انگلیسی

Transplantation of whole human pancreases or isolated islets into patients with type 1 diabetes mellitus has been severely hampered by the scarcity of cadaveric human donor organs, which mandates search for insulin producing cells/tissue source alternatives. Recent progress in stem cell biology has started looking into functionally competent, insulin-secreting progenitor cells. It had been previously observed that induced expression of the β-cell transcriptional factor of the pancreatic and duodenal homeobox gene1 (PDX1), in human hepatocytes, may activate multiple features of the β-cell phenotype. These “FH-B-TPN” cells were shown to release insulin in response to physiological glucose stimulation both, in vitro and in vivo. However, because FH-B-TPNs lack the expression of a number of β-cell or non β-cell genes, and are associated with low insulin content, we aimed to determine whether these cells, upon physical manipulation and envelopment within “clinical grade” alginate-based microcapsules, would reverse hyperglycemia after graft into diabetic animal models.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biomaterials - Volume 34, Issue 16, May 2013, Pages 4002–4012
نویسندگان
, , , , ,